MedTrace Logo

Assessment and Augmentation of Lip Appearance in Specific Study Populations

NCT04839692 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2023-07-28

Study results available
· View outcomes & findings →

Summary

This study aims to learn more about the effects of aging and lip filler treatment on lips and the surrounding skin by comparing, among two different age groups of people, changes in the blood vessels and nerves, volume, color and texture change before and after lip filler treatment and pain tolerance from lip filler treatment.

Conditions

  • Lip Aging
  • Lip Augmentation
  • Lip

Interventions

DRUG

Hyaluronic acid filler

Hyaluronic acid filler treatment of the lips with Restylane Kysse, which is a FDA approved treatment for lip augmentation.

Sponsors & Collaborators

  • Dieter Manstein, MD

    lead OTHER

Principal Investigators

  • Dieter Manstein, MD, PhD · Massachusetts General Hospital

  • Neera Nathan, MD, MSHS · Massachusetts General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-07
Primary Completion
2022-07-01
Completion
2022-08-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04839692 on ClinicalTrials.gov